HGH peptide therapy such as ipamorelin has been shown to provide: Improved libido and better sexual performance Increased energy and stamina Stronger and healthier bones Healthier hair and skin Increased ability to burn fat and build muscle Improved memory and cognition Return of an overall sense of health and wellbeing Growth hormone therapies are a widely accepted way to treat the negative effects of menopause and, according to The Journal of the American Medical Association, are most effective when started at the onset of menopause
Market Size & Forecast (2024-2031), By Product, USD Million Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Others Market Size & Forecast (2024-2031), By Route of Administration, USD Million Subcutaneous Oral Market Size & Forecast (2024-2031), By Application, USD Million Diabetes Obesity Others Market Size & Forecast (2024-2031), By End-user, USD Million Hospitals Specialty Clinics Home-care Settings Others Market Size & Forecast (2024-2031), By Region, USD Million North America US Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Latin America Middle East & Africa Key Strategic Questions Addressed What is the market size & forecast of the GLP-1 analogues market
Funck et al
Semaglutide and other GLP-1 receptor agonists have transformed weight loss treatment, with clinical trials showing average reductions of 1522% body weight over 68 weeks
Limited evidence but reasonable to try given low risk
